Year: 2023

FULL TILT BLUE RASPBERRY LEMONADE GUMMYFULL TILT BLUE RASPBERRY LEMONADE GUMMYFULL TILT VAPEFULL TILT VAPETORONTO, Oct. 30, 2023 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced the launch of two new THCV-infused products; Spinach FEELZ™ Full Tilt THCV vape and gummy. Cronos also plans to launch a THCV-infused pre-roll under the Spinach FEELZ™ brand, which will add an additional offering under its robust and growing pre-roll portfolio. The Full Tilt THCV lineup is designed to give adult consumers an exciting new cannabis experience. The Spinach FEELZ™ Full Tilt product range includes:Spinach FEELZ™ Full Tilt Blue Razz Durban 7:1 THC|THCV vape700mg of THC and 100mg of THCV per 1g cartridgeSpinach...

VANCOUVER, British Columbia, Oct. 30, 2023 (GLOBE NEWSWIRE) — Marimaca Copper Corp. (“Marimaca Copper” or the “Company”) (TSX: MARI) is pleased to announce the appointment of Ausenco Chile Limitada (“Ausenco”) to lead the Marimaca Project Definitive Feasibility Study (the “DFS”), following a competitive bidding process. Ausenco is a leading multi-national engineering firm with significant experience in Chile, including the current execution of the engineering, procurement and construction contract (“EPC”) for Capstone Copper’s Mantoverde Development Project. The firm has a wealth of experience and is already familiar with the Marimaca Copper Project (the “Project”) having led the 2020 Preliminary Economic Assessment (the “2020 PEA”) and subsequent trade-off studies for the Project. Ausenco will lead the DFS engineering workstreams...

Blue Point’s 19th Annual Cask Ales Festival will be held on November 4th at Blue Point Brewery in Patchogue, NY, and will Feature 60+ Breweries and Live Music from The Warped Tour Band, Evil Sweet, DJ Kaution, and MoreBlue Point Brewing Co. Introduces new Mother Pumpkin Ale for the seasonMother Pumpkin Ale: Spooky season is here, and we’re coming in hot with a refreshed look on the shelf.Blue Point Brewing Company’s highly anticipated Annual Cask Ales Festival returns!The event, in partnership with Long Island Cares, is set to take place on Saturday, November 4th, and promises a mix of live music, local vendors, food trucks, and, of course, a wide array of cask ales from breweries around the country.Blue Point Brewing Introduces New Winter Warmer BeerWinter Warmer: Winters in New York can be unforgiving....

PONTE VEDRA, Fla., Oct. 30, 2023 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions) through its Lapiplasty® 3D Bunion Correction® Procedure, today announced that John T. Treace, Chief Executive Officer, and Mark L. Hair, Chief Financial Officer, will participate in a fireside chat at the Stifel 2023 Healthcare Conference on Tuesday, November 14, 2023, beginning at approximately 8:35 am ET. A live webcast and replay of the fireside chat will be available on the Company’s investor relations website at https://investors.treace.com/. Internet Posting of Information Treace routinely posts information that may be important to investors in the “Investor Relations” section...

CAMBRIDGE, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR) a biotechnology company dedicated to breaking through barriers in gene therapy and neurology, today announced it will report third quarter 2023 financial and operating results after market close on Monday, November 6, 2023. Subsequently, the Company will host a conference call and webcast at 4:30 p.m. ET to review its financial and operating results. To participate via telephone and join the call live, please register in advance here. Upon registration, telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number and a unique passcode. A live webcast of the call will also be available on the Investors section of the Voyager website at ir.voyagertherapeutics.com, and a replay...

PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023 at 2:30 p.m. ET. A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the event. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical stage genetic medicines company on a mission to provide life-transforming therapies for patients with CNS...

Research Directed by Faculty of the Center for Transplantation Sciences, Massachusetts General Hospital TNX-1500 is currently in Phase 1 Clinical Development Tonix is Developing TNX-1500 for Prevention of Kidney Allograft Rejection as the First Indication; Multiple Other Indications, including Autoimmune Disorders, are Planned CHATHAM, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a biopharmaceutical company with marketed products and a pipeline of development candidates, today announced data from two oral presentations which were delivered recently at the American College of Surgeons (ACS) Clinical Congress 2023, and The International Pancreas and Islet Transplant Association (IPITA), the International Xenotransplantation Association (IXA), and the Cell Transplant...

Platinum Group Element and Nickel Sulfide Mineralization Intersected up to 400 m Outside Existing Trapiá 1 ResourceFigure 1Pedra Branca PGE Project property map, highlighting locations of the 2023 drill targets and currently defined resource zones.Figure 2Trapiá 1 Deposit long section (looking NE) highlighting location of the holes drilled in 2023, representing a collective 400 m step-out drilling, with PGE mineralization intercepted in all four holes.Figure 3Semi-massive to brecciated sulfides intersected in DD23TU32, with nickel-sulfide grades up to 1.35% Ni, and copper up to 0.29% Cu. Dominant sulfide is pyrrhotite, with subordinate pentlandite and chalcopyrite.VANCOUVER, British Columbia, Oct. 30, 2023 (GLOBE NEWSWIRE) — ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0, “the...

WATERTOWN, Mass., Oct. 30, 2023 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with retinal diseases, today announced that the Company will present at upcoming medical meetings and an investor conference. Presentation details are as follows: Eyecelerator 2023 Title: The Year in ReviewForum: Panel DiscussionDate: Thursday, November 2, 2023Time: 8:10 a.m. PT / 11:10 a.m. ETPresenter: Jay S. Duker, M.D., President & Chief Executive Officer of EyePoint Pharmaceuticals Dr. Duker will present interim masked safety data through October 1, 2023, in which approximately 173 patients have received EYP-1901 with a minimum of four months of follow-up post injection from the ongoing Phase 2 PAVIA and DAVIO...

Standardizes and improves product reimbursement process New HCPCS Level II code J1105 to be effective January 1, 2024 NEW HAVEN, Conn., Oct. 30, 2023 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that the Centers for Medicare & Medicaid Services (CMS) has issued a permanent and product-specific J-Code for IGALMI™ (dexmedetomidine) sublingual film, which is approved for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults1,2. Under the Healthcare Common Procedure Coding System (HCPCS) process, the IGALMI J-Code J1105 will become effective January 1, 2024. J-codes are permanent codes used by healthcare providers, commercial insurance...